Our results demonstrate that accumulation of UBB+1 in the brain is an early event in AD pathogenesis and that increased expression of UBB+1 is sufficient to induce AD-like pathology (i.e., Aβ-containing plaques and phosphorylated tau aggregates) in human neurons. This evidence concerns the gene MAPT and Alzheimer disease.